ManagerThis thread is no longer being updated. To see the most up to date list of companies, please go to the Cochlear Pro website.
This is a list of biotech companies developing cures for inner ear damage and disorders (hearing and balance).
With reservation for errors, such as name of the CEO or the name of the product and target indication.
CH: Auris Medical
http://www.aurismedical.com/
Founded in 2003
CEO: Thomas Meyer (Ph.D.)
AM-101, Acute/Post-acute inner ear tinnitus
AM-111, ASNHL (sudden deafness)
AM-125, Meniere's disease & Vestibular vertigo
AM-102, Tinnitus
http://www.aurismedical.com/
Founded in 2003
CEO: Thomas Meyer (Ph.D.)
AM-101, Acute/Post-acute inner ear tinnitus
AM-111, ASNHL (sudden deafness)
AM-125, Meniere's disease & Vestibular vertigo
AM-102, Tinnitus
DE: Böhringer Ingelheim
http://www.boehringer-ingelheim.com/
Founded in 1885
CEO: Andreas Barner (Prof.)
Regeneration of hair cells from inner ear stem cells
http://www.boehringer-ingelheim.com/
Founded in 1885
CEO: Andreas Barner (Prof.)
Regeneration of hair cells from inner ear stem cells
DE: Acousia Therapeutics
http://www.acousia.com/
Founded in 2012
CEO: Hubert Löwenheim (MD, Ph.D, Prof.)
Prevention and treatment of hearing loss.
Discuss it here: Acousia thread
http://www.acousia.com/
Founded in 2012
CEO: Hubert Löwenheim (MD, Ph.D, Prof.)
Prevention and treatment of hearing loss.
Discuss it here: Acousia thread
DE: AudioCure Pharma
http://audiocure.de/
Founded in 2010
CEO: Hans Rommelspacher (Ph.D, Prof.)
AC-002, Increase of key growth factors for neuronal repair
AC-002, Anti-oxidant action (decrease of reactive oxygen species)
AC-002, Protection of cells from cisplatin-induced cell death
http://audiocure.de/
Founded in 2010
CEO: Hans Rommelspacher (Ph.D, Prof.)
AC-002, Increase of key growth factors for neuronal repair
AC-002, Anti-oxidant action (decrease of reactive oxygen species)
AC-002, Protection of cells from cisplatin-induced cell death
ES: Spiral Therapeutics
http://spiraltx.com/
Founded in 2016
CEO: Hugo Peris
Therapies targeting inner ear disorders.
http://spiraltx.com/
Founded in 2016
CEO: Hugo Peris
Therapies targeting inner ear disorders.
FR: Affichem
http://www.affichem.com/
Founded in 2002
CEO, US: Jennifer Seibert (MBA, MSc.)
CEO, FR: Stéphane Silvente (MS, MBA)
AF243, a drug to restore hearing.
http://www.affichem.com/
Founded in 2002
CEO, US: Jennifer Seibert (MBA, MSc.)
CEO, FR: Stéphane Silvente (MS, MBA)
AF243, a drug to restore hearing.
FR: Sensorion Pharma
http://www.sensorion-pharma.com/en/
Founded in 2009
CEO: Laurent Nguyen (MD)
(SR1001, Neurology of the inner ear)
SENS-111, Vertigo
SENS-218, Vestibular lesions
SENS-300, Drug-induced ototoxicity
SENS-401, Sudden Sensorineural Hearing Loss
http://www.sensorion-pharma.com/en/
Founded in 2009
CEO: Laurent Nguyen (MD)
(SR1001, Neurology of the inner ear)
SENS-111, Vertigo
SENS-218, Vestibular lesions
SENS-300, Drug-induced ototoxicity
SENS-401, Sudden Sensorineural Hearing Loss
NL: Audion Therapeutics
http://www.audiontherapeutics.com/
Founded in 2009
CEO: Rolf Jan Rutten
Hearing loss regeneration & drug delivery methods.
http://www.audiontherapeutics.com/
Founded in 2009
CEO: Rolf Jan Rutten
Hearing loss regeneration & drug delivery methods.
UK: Autifony Therapeutics
http://www.autifonytherapeutics.com/
Founded in 2011
CEO: Charles Large (Ph.D.)
AUT00063, Age-related hearing loss & subjective tinnitus
http://www.autifonytherapeutics.com/
Founded in 2011
CEO: Charles Large (Ph.D.)
AUT00063, Age-related hearing loss & subjective tinnitus
US: Inception3/Roche
http://www.inceptionsci.com/
Founded in 2011
CEO: Peppi Prasit (Ph.D.)
Inception 3, Sensorineural hearing loss
http://www.inceptionsci.com/
Founded in 2011
CEO: Peppi Prasit (Ph.D.)
Inception 3, Sensorineural hearing loss
US: SciFluor Life
http://www.scifluor.com/
Founded in 2011
CEO: Omar Amirana (M.D.)
SF0034, treating epilepsy and tinnitus
http://www.scifluor.com/
Founded in 2011
CEO: Omar Amirana (M.D.)
SF0034, treating epilepsy and tinnitus
US: Knopp Biosciences
http://knoppbio.com/
Founded in 2004
CEO: Michael E. Bozik (M.D.)
Treating epilepsy and tinnitus
http://knoppbio.com/
Founded in 2004
CEO: Michael E. Bozik (M.D.)
Treating epilepsy and tinnitus
US: Frequency Therapeutics
http://www.frequencytx.com/
Founded in 2015
CEO: David Lucchino
Noise induced hearing loss
Discuss it here: Frequency thread
http://www.frequencytx.com/
Founded in 2015
CEO: David Lucchino
Noise induced hearing loss
Discuss it here: Frequency thread
US: GenVec/Novartis
http://www.genvec.com/
Founded in 1992
CEO: Douglas J. Swirsky (CPA, CFA)
CGF-166, Hearing loss and vestibular dysfunction
http://www.genvec.com/
Founded in 1992
CEO: Douglas J. Swirsky (CPA, CFA)
CGF-166, Hearing loss and vestibular dysfunction
US: Otonomy
http://www.otonomy.com/
Founded in 2008
CEO: David A. Weber (Ph.D)
OTO-104, Meniere's disease
OTO-201, Acute otitis media with tubes
OTO-311, Tinnitus
OTO-4XX, Sensorineural hearing loss
Discuss it here: Otonomy thread
http://www.otonomy.com/
Founded in 2008
CEO: David A. Weber (Ph.D)
OTO-104, Meniere's disease
OTO-201, Acute otitis media with tubes
OTO-311, Tinnitus
OTO-4XX, Sensorineural hearing loss
Discuss it here: Otonomy thread
US: Quark Pharma
http://quarkpharma.com/
Founded in 1994
CEO: Daniel Zurr (Ph.D.)
QP-HL1 Otoprotection
QP-HL2 Meniere's disease
QP-HL3 Hearing regeneration
http://quarkpharma.com/
Founded in 1994
CEO: Daniel Zurr (Ph.D.)
QP-HL1 Otoprotection
QP-HL2 Meniere's disease
QP-HL3 Hearing regeneration
US: Sound Pharmaceuticals
http://soundpharma.com/
Founded in 2001
CEO: Eric D. Lynch (Ph.D.)
SPI-1005, Acute NIHL Mild to Moderate, Meniere's Disease
SPI-3005, Chemotherapy-Induced Ototoxicity, Aminoglycoside-Induced Ototoxicity
SPI-5557, Severe to Profoundly Impaired hearing, regeneration
http://soundpharma.com/
Founded in 2001
CEO: Eric D. Lynch (Ph.D.)
SPI-1005, Acute NIHL Mild to Moderate, Meniere's Disease
SPI-3005, Chemotherapy-Induced Ototoxicity, Aminoglycoside-Induced Ototoxicity
SPI-5557, Severe to Profoundly Impaired hearing, regeneration
US: Oricula Therapeutics
http://www.oricularx.com/
Founded in 2013
CEO: Malcolm Gleser (MD, Ph.D.)
ORC-0001, protect hair cells from aminoglycosides
http://www.oricularx.com/
Founded in 2013
CEO: Malcolm Gleser (MD, Ph.D.)
ORC-0001, protect hair cells from aminoglycosides
US: Decibel Therapeutics
https://decibeltx.com/
Founded in 2015
CEO: Steven H. Holtzman (Ph.D.)
Protect, repair and restore hearing
https://decibeltx.com/
Founded in 2015
CEO: Steven H. Holtzman (Ph.D.)
Protect, repair and restore hearing
US: AGTC (in preparation)
https://www.agtc.com/
Founded in 1999
CEO: Susan B. Washer (MBA, BS)
Exploring genetic defects in cells in the inner ear
https://www.agtc.com/
Founded in 1999
CEO: Susan B. Washer (MBA, BS)
Exploring genetic defects in cells in the inner ear
US: Otologic Pharmaceutics
http://otologicpharmaceutics.com/
Founded in 2009
CEO: Clayton I. Duncan (MBA, MA)
NHPN-1010, Otoprotectant, prevent and treat acute hearing loss, prevent permanent hearing disorders, acute noise induced hearing loss, treat tinnitus, vestibular injury and traumatic brain injury associated hearing disorders
http://otologicpharmaceutics.com/
Founded in 2009
CEO: Clayton I. Duncan (MBA, MA)
NHPN-1010, Otoprotectant, prevent and treat acute hearing loss, prevent permanent hearing disorders, acute noise induced hearing loss, treat tinnitus, vestibular injury and traumatic brain injury associated hearing disorders
US: Fennec Pharmaceuticals
http://fennecpharma.com/
Founded in 1996
CEO: Rostislav Raykov (BSBA)
Sodium Thiosulfate (STS), Reducing Ototoxicity in Patients Receiving Cisplatin Chemotherapy
http://fennecpharma.com/
Founded in 1996
CEO: Rostislav Raykov (BSBA)
Sodium Thiosulfate (STS), Reducing Ototoxicity in Patients Receiving Cisplatin Chemotherapy
US: Anida Pharma
http://www.anidapharma.com/
CEO: Per Gjorstrup (M.D. & Ph.D.)
Neuroprotectin D1 (NPD1), Drug-induced hearing loss
http://www.anidapharma.com/
CEO: Per Gjorstrup (M.D. & Ph.D.)
Neuroprotectin D1 (NPD1), Drug-induced hearing loss
Rescue Hearing
http://rescuehearing.com/
http://rescuehearing.com/
Last edited:
